Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $8.39 | Prev. Close $8.42 | Circuit Range N/A |
Day Range $8.34 - $8.60 | Year Range $5.01 - $11.96 | Volume 1,28,286 |
Average Traded $8.48 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Apr-26 | $8.39 | $8.53 | +0.00% |
09-Apr-26 | $8.39 | $8.53 | +1.19% |
08-Apr-26 | $8.47 | $8.43 | +5.38% |
07-Apr-26 | $7.83 | $8.00 | +0.50% |
06-Apr-26 | $7.85 | $7.96 | +3.11% |
02-Apr-26 | $7.62 | $7.72 | -3.50% |
01-Apr-26 | $8.22 | $8.00 | -1.84% |